drugset / Trial / NCT02633514
Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is designed to investigate whether adjuvant radiochemotherapy after incomplete resection has a better survival than adjuvant radiotherapy for thymoma or thymic carcinoma.
Timeline
- Start
- 2023-12-01
- Primary completion
- 2024-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 25 mg/m2 | Intravenous |
| Subject | Etoposide | Small molecule | 75 mg/m2 | Intravenous |